A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Public ClinicalTrials.gov record NCT05567783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIR-2482 compared to placebo in preventing influenza A illness in healthy adults 18 to \<65 years of age without pre-existing risk factors for serious complications from influenza infection.
Study identification
- NCT ID
- NCT05567783
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 2,977 participants
Conditions and interventions
Conditions
Interventions
- VIR-2482 (450 mg) Biological
- VIR-2482 (1200 mg) Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2022
- Primary completion
- May 4, 2023
- Completion
- Aug 30, 2023
- Last update posted
- Sep 18, 2024
2022 – 2023
United States locations
- U.S. sites
- 51
- U.S. states
- 25
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Anniston | Alabama | 36207 | — |
| Investigative Site | Mobile | Alabama | 36608 | — |
| Investigative Site | Tempe | Arizona | 85281 | — |
| Investigative Site | Long Beach | California | 90805 | — |
| Investigative Site | Pomona | California | 91767 | — |
| Investigative Site | San Diego | California | 92123 | — |
| Investigative Site | Aurora | Colorado | 80918 | — |
| Investigative Site | Longmont | Colorado | 80501 | — |
| Investigative Site | Fort Myers | Florida | 33912 | — |
| Investigative Site | Jupiter | Florida | 33458 | — |
| Investigative Site | Miami | Florida | 33144 | — |
| Investigative Site | Miami | Florida | 33165 | — |
| Investigative Site | Pembroke Pines | Florida | 33024 | — |
| Investigative Site | Winter Park | Florida | 32789 | — |
| Investigative Site | Lilburn | Georgia | 30047 | — |
| Investigative Site | Meridian | Idaho | 83642 | — |
| Investigative Site | Chicago | Illinois | 60625 | — |
| Investigative Site | South Bend | Indiana | 46617 | — |
| Investigative Site | El Dorado | Kansas | 67042 | — |
| Investigative Site | Lenexa | Kansas | 66219 | — |
| Investigative Site | Wichita | Kansas | 67205 | — |
| Investigative Site | Lexington | Kentucky | 40509 | — |
| Investigative Site | Versailles | Kentucky | 40383 | — |
| Investigative Site | Metairie | Louisiana | 70006 | — |
| Investigative Site | New Orleans | Louisiana | 70115 | — |
| Investigative Site | Methuen | Massachusetts | 01844 | — |
| Investigative Site | Kansas City | Missouri | 64114 | — |
| Investigative Site | Las Vegas | Nevada | 89030 | — |
| Investigative Site | Las Vegas | Nevada | 89102 | — |
| Investigative Site | Rochester | New York | 14618 | — |
| Investigative Site | Monroe | North Carolina | 28112 | — |
| Investigative Site | Raleigh | North Carolina | 27612 | — |
| Investigative Site | Cincinnati | Ohio | 45242 | — |
| Investigative Site | Edmond | Oklahoma | 73013 | — |
| Investigative Site | Yukon | Oklahoma | 73099 | — |
| Investigative Site | Anderson | South Carolina | 29621 | — |
| Investigative Site | North Charleston | South Carolina | 29405 | — |
| Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Investigative Site | Rapid City | South Dakota | 57702 | — |
| Investigative Site | Elizabethton | Tennessee | 37643 | — |
| Investigative Site | Knoxville | Tennessee | 37909 | — |
| Investigative Site | Austin | Texas | 78705 | — |
| Investigative Site | Austin | Texas | 78745 | — |
| Investigative Site | Cedar Park | Texas | 78613 | — |
| Investigative Site | Dallas | Texas | 75251 | — |
| Investigative Site | Houston | Texas | 77055 | — |
| Investigative Site | San Angelo | Texas | 76904 | — |
| Investigative Site | San Antonio | Texas | 78229 | — |
| Investigative Site | Tomball | Texas | 77375 | — |
| Investigative Site | Layton | Utah | 84041 | — |
| Investigative Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05567783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05567783 live on ClinicalTrials.gov.